Mangione C M, Gutierrez P R, Lowe G, Orav E J, Seddon J M
Department of Medicine, UCLA School of Medicine, Los Angeles, California 90024-8012, USA.
Am J Ophthalmol. 1999 Jul;128(1):45-53. doi: 10.1016/s0002-9394(99)00169-5.
To describe the influence of age-related maculopathy on visual functioning and health-related quality of life.
A prospective, cross-sectional, observational cohort sample of 201 persons with various stages of age-related maculopathy was recruited from the Massachusetts Eye and Ear Infirmary as part of a longitudinal study of age-related macular degeneration. Persons were considered to have age-related maculopathy if one or more of the following clinical characteristics were present: drusen, retinal pigment epithelial changes, geographic atrophy, or evidence of exudative disease. Median corrected visual acuity for this sample was 20/25 in the better eye, with all subjects having 20/200 or better visual acuity in at least one eye at baseline. All participants underwent a comprehensive ophthalmologic examination with a dilated pupil. In addition to the usual clinical data collection, severity of age-related maculopathy was graded by an ophthalmologist who used standard clinical criteria and was masked to the participants' descriptions of visual functioning and health-related quality of life. All participants completed an interview that included the Activities of Daily Vision Scale, a survey designed to assess difficulties with routine daily activities that require vision, and the Short Form-36 Health Survey, a generic measure of multidimensional health-related quality of life.
Severity of age-related maculopathy was associated with poorer scores of the Activities of Daily Vision Scale. This association was most significant for near vision and driving activities. In this sample, the SF-36 Health Survey scales were not significantly correlated with severity of age-related maculopathy.
Reported visual functioning is significantly associated with the clinical severity of age-related maculopathy. However, once visual acuity is taken into consideration, clinical grading of age-related maculopathy did not explain a significant portion of the variation in visual functioning. The lack of significant correlation between severity of age-related maculopathy and the SF-36 Health Survey may have resulted from the small number of participants in our sample with severe bilateral age-related maculopathy.
描述年龄相关性黄斑病变对视觉功能及与健康相关生活质量的影响。
作为年龄相关性黄斑变性纵向研究的一部分,从马萨诸塞州眼耳医院招募了201名处于不同阶段年龄相关性黄斑病变的前瞻性、横断面观察队列样本。如果存在以下一项或多项临床特征,则认为患有年龄相关性黄斑病变:玻璃膜疣、视网膜色素上皮改变、地图样萎缩或渗出性疾病证据。该样本较好眼的矫正视力中位数为20/25,所有受试者在基线时至少一只眼的视力为20/200或更好。所有参与者均接受了散瞳后的全面眼科检查。除了常规临床数据收集外,年龄相关性黄斑病变的严重程度由一名眼科医生根据标准临床标准进行分级,该医生对参与者的视觉功能描述和与健康相关生活质量不知情。所有参与者均完成了一次访谈,其中包括日常视觉活动量表,这是一项旨在评估需要视力的日常活动困难程度的调查,以及简短健康调查-36,这是一种对与健康相关生活质量进行多维度测量的通用方法。
年龄相关性黄斑病变的严重程度与日常视觉活动量表得分较低相关。这种关联在近视力和驾驶活动方面最为显著。在该样本中,简短健康调查-36量表与年龄相关性黄斑病变的严重程度无显著相关性。
报告的视觉功能与年龄相关性黄斑病变的临床严重程度显著相关。然而,一旦考虑到视力,年龄相关性黄斑病变的临床分级并不能解释视觉功能变化的很大一部分。年龄相关性黄斑病变严重程度与简短健康调查-36之间缺乏显著相关性,可能是由于我们样本中患有严重双侧年龄相关性黄斑病变的参与者数量较少。